eEF2, an oncogenic translational regulator, becomes a new IGF2BP1 target mRNA, allowing BTYNB to effectively inhibit the proliferation of OC and melanoma cells containing IGF2BP1 [209]. This evidence concerns the gene IGF2BP1 and melanoma.